Mercy Hospital Cancer Center - Scranton — Scranton, Pennsylvania

Mercy Hospital Cancer Center - Scranton is a clinical research site located in Scranton, Pennsylvania, United States 18501.

Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

Mercy Hospital Cancer Center - Scranton has participated in 73 clinical trials with 2 currently active.

Therapeutic areas: Breast Cancer, Metastatic Cancer, Lymphoma.

Sponsors: NSABP Foundation Inc, Pharmacyclics LLC., Eastern Cooperative Oncology Group.

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mercy Hospital Cancer Center - Scranton?

Mercy Hospital Cancer Center - Scranton has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mercy Hospital Cancer Center - Scranton conducted?

Mercy Hospital Cancer Center - Scranton has 73 clinical trials on record, with 2 currently active. Their work covers Breast Cancer, Metastatic Cancer, Lymphoma.

Is Mercy Hospital Cancer Center - Scranton accredited by Crixeo Health?

Mercy Hospital Cancer Center - Scranton has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mercy Hospital Cancer Center - Scranton?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.